Holocene Advisors’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
CCM
GC
ACM
EMFAT
Holocene Advisors's TECX Position: Q1 2021 in Review
Holocene Advisors sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 95,143 shares — an estimated $15.9M sold.
Holocene Advisors first reported a position in TECX in Q1 2020 and held it in 4 quarters. The position peaked at $15.9M in Q4 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.
- Holocene Advisors reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
- Holocene Advisors sold 95,143 Tectonic Therapeutic shares in Q1 2021, an estimated $15.9M.
- Holocene Advisors first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 4 quarters.
- Holocene Advisors's Tectonic Therapeutic position peaked at $15.9M in Q4 2020.
- 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.
Based on Holocene Advisors's 13F filing for Q1 2021, filed 17 May 2021.